Literature DB >> 7658082

Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA.

E N Janoff1, S M Wahl, K Thomas, P D Smith.   

Abstract

The effect of IgA from human immunodeficiency virus type 1 (HIV-1)-infected patients on infection of primary human blood monocytes with the monocyte-tropic strain HIV-1Bal was evaluated in vitro. Preincubation of HIV-1Bal with purified serum IgA from 6 of 14 patients but from none of 5 seronegative subjects caused a > 50% increase in reverse transcriptase activity. This increase was inhibited by preincubation of monocytes with nonimmune IgA, suggesting a role for Fc alpha receptors. Results were independent of CD4 T cell number and clinical stage. The IgA-mediated enhancement extended to more biologically relevant human mononuclear cells isolated from the intestinal lamina propria. The ability of serum IgA to enhance HIV-1 infection may be relevant to infection of both circulating monocytes and mucosal macrophages. These studies suggest the need to characterize the complex contribution of IgA and the mucosal immune system in promoting and preventing primary HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658082     DOI: 10.1093/infdis/172.3.855

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.

Authors:  Sharon M Wahl; Maryann Redford; Shawna Christensen; Wendy Mack; Jon Cohn; Edward N Janoff; Jiri Mestecky; Hal B Jenson; Mahvash Navazesh; Mardge Cohen; Patricia Reichelderfer; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

2.  Genetic variants of the IgA Fc receptor (FcalphaR, CD89) promoter in chronic hepatitis C patients.

Authors:  Azuma Watanabe; Toshibumi Shimokawa; Mitsuhiko Moriyama; Fumihiko Komine; Shuichi Amaki; Yasuyuki Arakawa; Chisei Ra
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

3.  Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.

Authors:  F Schäfer; S Kewenig; N Stolte; C Stahl-Hennig; A Stallmach; F-J Kaup; M Zeitz; T Schneider
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.

Authors:  G J Gorse; E Y Yang; R B Belshe; P W Berman
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants.

Authors:  Louise Kuhn; Daria Trabattoni; Chipepo Kankasa; Moses Sinkala; Francesca Lissoni; Mrinal Ghosh; Grace Aldrovandi; Don Thea; Mario Clerici
Journal:  J Pediatr       Date:  2006-11       Impact factor: 4.406

6.  HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.

Authors:  L Musey; Y Hu; L Eckert; M Christensen; T Karchmer; M J McElrath
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

7.  The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection.

Authors:  Eleonora Castelletti; Sergio Lo Caputo; Louise Kuhn; Manuela Borelli; Johanna Gajardo; Moses Sinkala; Daria Trabattoni; Chipepo Kankasa; Eleonora Lauri; Alberto Clivio; Luca Piacentini; Dorothy H Bray; Grace M Aldrovandi; Donald M Thea; Francisco Veas; Manuela Nebuloni; Francesco Mazzotta; Mario Clerici
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

8.  Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.

Authors:  Melissa Ghulam-Smith; Alex Olson; Laura F White; Charles S Chasela; Sascha R Ellington; Athena P Kourtis; Denise J Jamieson; Gerald Tegha; Charles M van der Horst; Manish Sagar
Journal:  mBio       Date:  2017-10-24       Impact factor: 7.867

Review 9.  Are anti-HIV IgAs good guys or bad guys?

Authors:  Mingkui Zhou; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2014-12-14       Impact factor: 4.602

10.  As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention.

Authors:  Craig R Travis
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.